Drug Profile
Reldesemtiv - Astellas Pharma/Cytokinetics
Alternative Names: CK-107; CK-2127107Latest Information Update: 11 Dec 2023
Price :
$50
*
At a glance
- Originator Cytokinetics
- Developer Astellas Pharma; Cytokinetics
- Class Amides; Cyclobutanes; Fluorinated hydrocarbons; Pyridines; Pyrimidines; Pyrroles; Small molecules
- Mechanism of Action Troponin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Amyotrophic lateral sclerosis; Chronic obstructive pulmonary disease; Muscle fatigue; Muscular atrophy